Your browser doesn't support javascript.
loading
Precision RNAi using synthetic shRNAmir target sites.
Hoffmann, Thomas; Hörmann, Alexandra; Corcokovic, Maja; Zmajkovic, Jakub; Hinterndorfer, Matthias; Salkanovic, Jasko; Spreitzer, Fiona; Köferle, Anna; Gitschtaler, Katrin; Popa, Alexandra; Oberndorfer, Sarah; Andersch, Florian; Schaefer, Markus; Fellner, Michaela; Budano, Nicole; Ruppert, Jan G; Chetta, Paolo; Wurm, Melanie; Zuber, Johannes; Neumüller, Ralph A.
Afiliación
  • Hoffmann T; Research Institute of Molecular Pathology (IMP), Campus-Vienna-Biocenter 1, Vienna, Austria.
  • Hörmann A; Vienna BioCenter PhD Program, Doctoral School of the University at Vienna and Medical University of Vienna, Vienna BioCenter (VBC), Vienna, Austria.
  • Corcokovic M; Boehringer Ingelheim RCV GmbH & Co KG, Doktor-Boehringer-Gasse, Vienna, Austria.
  • Zmajkovic J; Boehringer Ingelheim RCV GmbH & Co KG, Doktor-Boehringer-Gasse, Vienna, Austria.
  • Hinterndorfer M; Research Institute of Molecular Pathology (IMP), Campus-Vienna-Biocenter 1, Vienna, Austria.
  • Salkanovic J; Research Institute of Molecular Pathology (IMP), Campus-Vienna-Biocenter 1, Vienna, Austria.
  • Spreitzer F; Boehringer Ingelheim RCV GmbH & Co KG, Doktor-Boehringer-Gasse, Vienna, Austria.
  • Köferle A; Boehringer Ingelheim RCV GmbH & Co KG, Doktor-Boehringer-Gasse, Vienna, Austria.
  • Gitschtaler K; Boehringer Ingelheim RCV GmbH & Co KG, Doktor-Boehringer-Gasse, Vienna, Austria.
  • Popa A; Boehringer Ingelheim RCV GmbH & Co KG, Doktor-Boehringer-Gasse, Vienna, Austria.
  • Oberndorfer S; Boehringer Ingelheim RCV GmbH & Co KG, Doktor-Boehringer-Gasse, Vienna, Austria.
  • Andersch F; Boehringer Ingelheim RCV GmbH & Co KG, Doktor-Boehringer-Gasse, Vienna, Austria.
  • Schaefer M; Research Institute of Molecular Pathology (IMP), Campus-Vienna-Biocenter 1, Vienna, Austria.
  • Fellner M; Research Institute of Molecular Pathology (IMP), Campus-Vienna-Biocenter 1, Vienna, Austria.
  • Budano N; Research Institute of Molecular Pathology (IMP), Campus-Vienna-Biocenter 1, Vienna, Austria.
  • Ruppert JG; Boehringer Ingelheim RCV GmbH & Co KG, Doktor-Boehringer-Gasse, Vienna, Austria.
  • Chetta P; Boehringer Ingelheim RCV GmbH & Co KG, Doktor-Boehringer-Gasse, Vienna, Austria.
  • Wurm M; Boehringer Ingelheim RCV GmbH & Co KG, Doktor-Boehringer-Gasse, Vienna, Austria.
  • Zuber J; Boehringer Ingelheim RCV GmbH & Co KG, Doktor-Boehringer-Gasse, Vienna, Austria.
  • Neumüller RA; Research Institute of Molecular Pathology (IMP), Campus-Vienna-Biocenter 1, Vienna, Austria.
Elife ; 122023 08 08.
Article en En | MEDLINE | ID: mdl-37552050
ABSTRACT
Loss-of-function genetic tools are widely applied for validating therapeutic targets, but their utility remains limited by incomplete on- and uncontrolled off-target effects. We describe artificial RNA interference (ARTi) based on synthetic, ultra-potent, off-target-free shRNAs that enable efficient and inducible suppression of any gene upon introduction of a synthetic target sequence into non-coding transcript regions. ARTi establishes a scalable loss-of-function tool with full control over on- and off-target effects.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferencia de ARN Idioma: En Revista: Elife Año: 2023 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferencia de ARN Idioma: En Revista: Elife Año: 2023 Tipo del documento: Article País de afiliación: Austria
...